Skip to main content
Press Release

Two Indicted for Trafficking Counterfeit Oxycodone Pills Containing Fentanyl

For Immediate Release
U.S. Attorney's Office, Eastern District of California

SACRAMENTO, Calif. — A federal grand jury returned a four-count indictment today charging Alfredo Sanchez, 39, of Madera, and Saybyn Borges, 27, of Sacramento, with conspiracy to distribute fentanyl, distribution of fentanyl, and possession with intent to distribute fentanyl, U.S. Attorney McGregor W. Scott announced. Sanchez was also charged with being a felon in possession of a firearm.

According to the indictment, between May 3, 2018, and June 7, 2018, in Placer, San Joaquin and Madera Counties, Sanchez and Borges conspired to distribute and possess with intent to distribute fentanyl. According to the criminal complaint, Sanchez and Borges were involved in the sale of approximately 7,500 counterfeit oxycodone pills that were found to contain fentanyl, a synthetic opioid.

A search warrant executed on Sanchez’s residence recovered four firearms: a Kel-Tec 12 gauge shotgun, Ruger .38-caliber revolver, Colt .38-caliber Mustang Pocketlite semi‑automatic pistol, and Colt Commander .38‑caliber pistol. Sanchez is prohibited from possessing firearms.

This case is the product of an investigation by the Drug Enforcement Administration Tactical Diversion Squad. Assistant U.S. Attorney Cameron L. Desmond is prosecuting the case.

If convicted of the fentanyl counts, Borges and Sanchez face a minimum five years and a maximum of life in prison and up to a $5 million fine. If convicted on the firearms possession charge, Sanchez faces up to 10 years in prison and a $250,000 fine. Any sentence, however, would be determined at the discretion of the court after consideration of any applicable statutory factors and the Federal Sentencing Guidelines, which take into account a number of variables. The charges are only allegations; the defendants are presumed innocent until and unless proven guilty beyond a reasonable doubt.

Updated July 24, 2018

Topics
Drug Trafficking
Opioids
Firearms Offenses
Press Release Number: 2:18-cr-136 TLN